![The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download](https://slideplayer.com/10734826/37/images/slide_1.jpg)
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download
![Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5835aee9687d11160fd503ad0ecb876e36789aca/3-Table1-1.png)
Table 1 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
![International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120619760-fx1ab.jpg)
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
![Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5835aee9687d11160fd503ad0ecb876e36789aca/3-Table3-1.png)
Table 3 from An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. | Semantic Scholar
![The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download](https://slideplayer.com/14444678/90/images/slide_1.jpg)
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma. - ppt download
![MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/083e8d4c130f77ea03d9c5e63e9a44b1ba076fdf/2-Table1-1.png)
MYC and BCL-2 adjusted-International Prognostic Index (A-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar
![ASCO 2020 Top 12” #6: Cause of Death in Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Stratified by the CLL-International Prognostic Index (CLL-IPI) - CLL Society ASCO 2020 Top 12” #6: Cause of Death in Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Stratified by the CLL-International Prognostic Index (CLL-IPI) - CLL Society](https://cllsociety.org/wp-content/uploads/2020/07/ASCO_6_Table.png)
ASCO 2020 Top 12” #6: Cause of Death in Patients with Newly Diagnosed Chronic Lymphocytic Leukemia (CLL) Stratified by the CLL-International Prognostic Index (CLL-IPI) - CLL Society
![Table 1 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar Table 1 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0ce5e3433e7e5c0a7252094d6a23f65336327517/2-Table1-1.png)
Table 1 from The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. | Semantic Scholar
![An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data - The Lancet Oncology An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data - The Lancet Oncology](https://www.thelancet.com/cms/attachment/05c65b0c-cdc3-4171-bd73-70de238ad3c0/gr1_lrg.jpg)
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data - The Lancet Oncology
![Kyle Bradley, MD on Twitter: "New CLL International Prognostic Index. Modern update to Rai and Binet staging systems. https://t.co/GRXAewz8FF https://t.co/YrIrOG4Ym6" / Twitter Kyle Bradley, MD on Twitter: "New CLL International Prognostic Index. Modern update to Rai and Binet staging systems. https://t.co/GRXAewz8FF https://t.co/YrIrOG4Ym6" / Twitter](https://pbs.twimg.com/media/CnqX1jgWgAAteoZ.jpg)
Kyle Bradley, MD on Twitter: "New CLL International Prognostic Index. Modern update to Rai and Binet staging systems. https://t.co/GRXAewz8FF https://t.co/YrIrOG4Ym6" / Twitter
![Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making | Leukemia Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-020-0791-3/MediaObjects/41375_2020_791_Fig2_HTML.png)
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making | Leukemia
![Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study](https://www.spandidos-publications.com/article_images/etm/4/3/ETM-04-03-0475-g01.jpg)